These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 34867987)
1. The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps. Gitto S; Natalini A; Antonangeli F; Di Rosa F Front Immunol; 2021; 12():755304. PubMed ID: 34867987 [TBL] [Abstract][Full Text] [Related]
2. Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy. Zuazo M; Arasanz H; Bocanegra A; Fernandez G; Chocarro L; Vera R; Kochan G; Escors D Front Immunol; 2020; 11():586907. PubMed ID: 33329566 [TBL] [Abstract][Full Text] [Related]
3. Resident memory T cells, critical components in tumor immunology. Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905 [TBL] [Abstract][Full Text] [Related]
4. Tissue-resident memory-like T cells in tumor immunity: Clinical implications. Dhodapkar MV; Dhodapkar KM Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063 [TBL] [Abstract][Full Text] [Related]
5. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment. Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554 [TBL] [Abstract][Full Text] [Related]
6. Tissue-resident memory CD8 Wang T; Shen Y; Luyten S; Yang Y; Jiang X Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340 [TBL] [Abstract][Full Text] [Related]
7. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade. Budimir N; Thomas GD; Dolina JS; Salek-Ardakani S Cancer Immunol Res; 2022 Feb; 10(2):146-153. PubMed ID: 34937730 [TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading. Azulay M; Shahar M; Shany E; Elbaz E; Lifshits S; Törngren M; Friedmann A; Kramer R; Hedlund G J Transl Med; 2023 Mar; 21(1):222. PubMed ID: 36967382 [TBL] [Abstract][Full Text] [Related]
14. Tissue-resident memory T cells in immunotherapy and immune-related adverse events by immune checkpoint inhibitor. Xiong H; Shen Z Int J Cancer; 2024 Jul; 155(2):193-202. PubMed ID: 38554117 [TBL] [Abstract][Full Text] [Related]
15. Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models. Takeda Y; Yoshida S; Takashima K; Ishii-Mugikura N; Shime H; Seya T; Matsumoto M Cancer Sci; 2018 Jul; 109(7):2119-2129. PubMed ID: 29791768 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy. van Pul KM; Fransen MF; van de Ven R; de Gruijl TD Front Immunol; 2021; 12():643291. PubMed ID: 33732264 [TBL] [Abstract][Full Text] [Related]
18. Fatty Acid Oxidation Controls CD8 Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801 [TBL] [Abstract][Full Text] [Related]
19. Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker. Wang Z; Wu X Cancer Med; 2020 Nov; 9(21):8086-8121. PubMed ID: 32875727 [TBL] [Abstract][Full Text] [Related]
20. The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers. Zhu L; Liu J; Chen J; Zhou Q J Hematol Oncol; 2021 Dec; 14(1):206. PubMed ID: 34930377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]